Trevena Inc. (TRVN) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for TRVN in the last 30 days. The most recent was published May 15, 2025.

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist that has completed Phase I clinical study for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR that has completed Phase I clinical study for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Latest news

25 items

TRVN FAQ

7 questions
  • What does Trevena Inc. do?
    Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist that has completed Phase I clinical study for...
  • What is the latest news on TRVN?
    Quantisnow has not tracked any new filings, ratings or press releases for TRVN in the last 30 days. The most recent wire item was published on May 15, 2025.
  • Where does TRVN stock trade?
    Trevena Inc. (TRVN) is listed on NASDAQ.
  • What sector and industry is TRVN in?
    Trevena Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Trevena Inc. go public?
    Trevena Inc. (TRVN) completed its IPO in 2014.
  • What companies are similar to TRVN?
    Notable peers in the same industry include MRK (Merck & Company Inc.), LLY (Eli Lilly and Company), NVO (Novo Nordisk A/S), ABT (Abbott Laboratories), JNJ (Johnson & Johnson). Compare TRVN side-by-side with any of them on Quantisnow.
  • How can I track TRVN on Quantisnow?
    Quantisnow aggregates Trevena Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TRVN to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change